Il nostro blog in lingua inglese sulla stimolazione transcranica a impulsi (TPS®). Qui troverete aggiornamenti regolari sulla nuova e moderna terapia per il trattamento della malattia di Alzheimer.
One of the highlights of the new NEUROLITH® system is its innovative BodyTrack software – a unique tool for the visualization and control of the TPS® pulses applied and of treatment progress. Real-time tracking of the handpiece position enables automatic visualization of the treated regions. The use of personalized MRI data allows specific characteristics of the patient’s brain to be taken into account.
»Overall, I feel good after the treatment and progress has been made. I notice that I respond well when someone talks to me and find the words to express myself better. In addition, my memory has improved somewhat. When I go shopping, I take the shopping list just to be on the safe side, although I could do without it.
Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system is performed by a trained practitioner and is done on an outpatient basis. During treatment, the patient sits comfortably in a chair and can move freely at any time. To ensure optimal transmission of the pulses, the therapist applies ultrasound gel to the scalp or hair – it is not necessary to shave the patient’s head. The patient then puts on a pair of special glasses so that the position of the head can be detected.
The authors of a follow-up study (published in 2021) investigated the possible benefits of TPS® treatment concerning brain morphology, namely the cortical atrophy characteristic of Alzheimer’s disease . They found a significant correlation between neuropsychological improvement and cortical thickness increase in AD-critical brain areas.
»Laughing and being happy - for healthy people this is normal. During my TPS® treatments, I notice that this is no longer normal for my patients. Many are sad and seem withdrawn. This is understandable when you can no longer do things the way you used to. I am all the more pleased when relatives call me after the first TPS® treatments with the NEUROLITH® or write to me that their loved ones are now happier again and that they are smiling more often.
In 2019, the clinical approval study for Transcranial Pulse Stimulation (TPS®) with STORZ MEDICAL’s NEUROLITH® system was published in the prestigious journal Advanced Science . Prof. Dr. Beisteiner’s study, which was conducted at the Medical University of Vienna Beisteiner, documents the positive effects of TPS in the treatment of patients with Alzheimer’s dementia.
The acoustic pulses generated by Transcranial Pulse Stimulation (TPS®) have been used successfully in various medical fields (urology, orthopaedics, cardiology….) for decades under the term »extracorporeal shock wave therapy«.
In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. The aim of TPS® is to boost the cognitive abilities of people with Alzheimer’s dementia by stimulating various regions of the brain and to maintain these abilities for as long as possible.